Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy

• 收藏
• 分享

专利权人:

Florian Colbatzky;Thomas Singer;Stefan Platz

发明人:

Thomas Singer,Stefan Platz,Florian Colbatzky

申请号：

US12706819

公开号：

US08431585B2

申请日:

2010.02.17

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention relates to the use of specific EGF-receptor antagonists for preparing a pharmaceutical composition for the prevention and/or treatment of benign prostatic hyperplasia and/or prostatic hypertrophy, a method for the treatment or prevention of benign prostatic hyperplasia/prostatic hypertrophy comprising administering an EGF-receptor antagonist of groups (A), (B) or (C), described herein optionally in combination with known compounds for the treatment of benign prostatic hyperplasia/prostatic hypertrophy, as well as associated pharmaceutical compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/